Drug Pipeline

Nirsevimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
1
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 4
3
Phase 3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07158814 Safety of RSV Preventive Monoclonal Antibody Fever Recruiting
NCT07109297 Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in… RSV Immunization Active, Not Recruiting
NCT07578298 THRIVE - Trial of Passive Humoral RSV Immunity for Value and Effectiveness Respiratory Syncytial Virus (RSV) Not Yet Recruiting
Phase 3
NCT07232706 Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or… RSV Immunization Recruiting
Phase 1/2
NCT07363837 Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term… Respiratory Syncytial Virus (RSV) Not Yet Recruiting
Sponsors Running Nirsevimab Trials
Get alerts when Nirsevimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free